Signal Bureau What’s happening · what the record shows

Lung Cancer

A topic on our watch list — we track its coverage across 10 domains, including Pubmed Targeted, Kras Research and Preprint.

If Lung Cancer is on your watch list: what changed in the coverage, what the reporting asserts, and what the crowd is pricing.

What’s changed

Therapeutic inhibition of RAS in non-small cell lung cancer. · Front Oncol · 2026-06-30
KRAS G12C-Targeted Therapy in Non-Small Cell Lung Cancer: From Resistant Salvage to Potential First-Line Backbone. · Int J Mol Sci · 2026-07-20
An IL-34-IGF-1 inflammatory axis fuels KRAS-mutant lung cancer progression. · bioRxiv · 2026-07-15
Next-Generation KRAS Inhibitors Show Promising Activity in Advanced Non–Small Cell Lung Cancer · The ASCO Post · 2026-07-14

Ask the engine about Lung Cancer ＋ Track Lung Cancer for a daily read

Informational only — not financial, legal, or investment advice. Prediction-market prices are shown as a signal of what the crowd believes. Terms · Privacy · page rendered Aug 6, 9:25 AM PT